These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9828926)

  • 1. [Clinical and pathological significance of p53 gene mutation in human cerebral glioblastoma multiforme].
    Matsumoto R
    Hokkaido Igaku Zasshi; 1998 Jul; 73(4):407-17. PubMed ID: 9828926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR overexpression and radiation response in glioblastoma multiforme.
    Barker FG; Simmons ML; Chang SM; Prados MD; Larson DA; Sneed PK; Wara WM; Berger MS; Chen P; Israel MA; Aldape KD
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):410-8. PubMed ID: 11567815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
    Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K
    Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans.
    Hung KS; Howng SL
    J Neurosurg; 2003 Nov; 99(5):886-92. PubMed ID: 14609169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.
    Tada M; Matsumoto R; Iggo RD; Onimaru R; Shirato H; Sawamura Y; Shinohe Y
    Cancer Res; 1998 May; 58(9):1793-7. PubMed ID: 9581814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
    Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY
    J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
    Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
    J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
    Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
    Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.
    Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.
    Heimberger AB; Hlatky R; Suki D; Yang D; Weinberg J; Gilbert M; Sawaya R; Aldape K
    Clin Cancer Res; 2005 Feb; 11(4):1462-6. PubMed ID: 15746047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.
    Bouvier-Labit C; Chinot O; Ochi C; Gambarelli D; Dufour H; Figarella-Branger D
    Neuropathol Appl Neurobiol; 1998 Oct; 24(5):381-8. PubMed ID: 9821169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants.
    Alimohammadi E; Bagheri SR; Sadeghsalehi A; Rizevandi P; Rezaie Z; Abdi A
    Acta Neurol Belg; 2020 Dec; 120(6):1341-1350. PubMed ID: 31222512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
    Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
    Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
    J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
    Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
    Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
    Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with increased survival after surgical resection of glioblastoma in octogenarians.
    Abdullah KG; Ramayya A; Thawani JP; Macyszyn L; Martinez-Lage M; O'Rourke DM; Brem S
    PLoS One; 2015; 10(5):e0127202. PubMed ID: 25978638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
    Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.